McKinley Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-735,307
| Closed | -$2.02M | – | 360 |
|
|
2017
Q4 | $2.02M | Buy |
735,307
+406,688
| +124% | +$1.11M | 0.1% | 155 |
|
|
2017
Q3 | $1.11M | Buy |
328,619
+5,011
| +2% | +$17K | 0.05% | 229 |
|
|
2017
Q2 | $799K | Hold |
323,608
| – | – | 0.03% | 247 |
|
|
2017
Q1 | $735K | Buy |
323,608
+141
| +0% | +$320 | 0.03% | 265 |
|
|
2016
Q4 | $686K | Buy |
+323,467
| New | +$686K | 0.03% | 268 |
|
|
2014
Q3 | – | Sell |
-450,047
| Closed | -$4.36M | – | 401 |
|
|
2014
Q2 | $4.36M | Sell |
450,047
-19,467
| -4% | -$188K | 0.18% | 133 |
|
|
2014
Q1 | $3.9M | Sell |
469,514
-21,086
| -4% | -$175K | 0.16% | 134 |
|
|
2013
Q4 | $4.14M | Buy |
490,600
+37,437
| +8% | +$316K | 0.16% | 130 |
|
|
2013
Q3 | $3.61M | Buy |
453,163
+285
| +0.1% | +$2.27K | 0.16% | 136 |
|
|
2013
Q2 | $3.5M | Buy |
+452,878
| New | +$3.5M | 0.18% | 124 |
|